BPMC Blueprint Medicines Corp

Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. Its drug candidates include BLU-285, BLU 554, and BLU-667.

$84.74  +1.05 (1.26%)
As of 06/24/2021 15:59:52 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/30/2015
Outstanding shares:  58,341,527
Average volume:  815,747
Market cap:   $4,842,346,741
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    09627Y109
ISIN:        US09627Y1091
Sedol:      BWY52P3
Valuation   (See tab for details)
PE ratio:   15.02
PB ratio:   3.48
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy